Bespoke Extracts, Inc.

Bespoke Extracts, Inc. is a U.S.-based cannabis products company that operates through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC. The company runs a marijuana-infused products manufacturing facility in Colorado and has shifted its focus from CBD offerings toward regulated cannabis markets in the United States. Its reported operating activity centers on producing and selling pre-rolled joints and providing joint production and processing services to licensed dispensaries and third parties. The business remains small and development-stage in nature, with management emphasizing expansion rather than a mature, diversified operating footprint.

−88,1 %

40,5 %

−92,8 %

+42,3 %

0.15

0.12

— Bespoke Extracts, Inc.
%
Branded cannabis products60% Finished cannabis products sold under the company's own product lines, including pre-rolled joints.
Contract manufacturing and production services25% Third-party joint production and related manufacturing services performed for other cannabis businesses.
Processing services15% Processing work for third parties that use the company's Colorado facility and operational capabilities.

The company's direct customers appear to be licensed dispensaries in Colorado that purchase pre-rolled joints for...

  • Licensed dispensaries in Coloradoprimary

    Buy pre-rolled joints for retail resale to adult-use or medical consumers in the Colorado cannabis market.

  • Third-party cannabis producerssecondary

    Outsource joint production and related manufacturing to access capacity and reduce fixed operating costs.

  • Processing clientssecondary

    Use the company's facility for processing services tied to cannabis product preparation and handling.

Bespoke Extracts' operating footprint is centered in Colorado, where its manufacturing facility and reported sales...

  • •Colorado is the core operating and sales market
  • •Manufacturing facility is located in Colorado
  • •Sales are tied to licensed dispensaries in Colorado
  • •Expansion target is regulated cannabis markets in the United States
  • •No disclosed international revenue or operating footprint

Management's stated strategy is to expand beyond CBD offerings and focus on regulated cannabis markets in the United...

01
Expand regulated cannabis product focusmedium-term

The company is repositioning away from CBD toward higher-opportunity regulated cannabis markets.

02
Increase production and service volumeshort-term

Higher throughput in joints and processing services is the main path to revenue growth in the current model.

03
Secure financing and working capitalshort-term

The company needs external capital to fund operations because it has not generated positive operating cash flow.

The company faces substantial going-concern and liquidity risk because it has not generated positive operating cash...

critical

Going-concern uncertainty

The company has negative operating cash flow, a working capital deficit, and no committed financing sources.

Scope
Ability to continue and expand operations
Materiality
high
high

Capital raising dependence

Operations have been funded primarily through equity and convertible debt, which may not be available on acceptable terms.

Scope
Liquidity and growth funding
Materiality
high
high

Colorado market concentration

Sales are concentrated in licensed dispensaries in Colorado, making results sensitive to one state market.

Scope
Revenue stability
Materiality
high
high

Cannabis regulatory risk

The business depends on state-level cannabis licensing and compliance, which can change or be restricted.

Scope
Operating permissions and customer access
Materiality
high
medium

Quarterly revenue volatility

Management explicitly notes potential fluctuation in quarterly results and rapid market changes.

Scope
Comparability and forecasting
Materiality
medium
Revenue recognition
Affects quarterly revenue timing and comparability
Accounts receivable allowance
Can materially affect reported earnings and cash conversion
Inventory valuation
Can create write-downs if demand weakens or products become obsolete
Deferred tax asset valuation allowance
Prevents recognition of tax assets until profitability is sustained

Charlie's Holdings, Inc.

CHUC · Medicinal Chemicals & Botanical Products

Bio Essence Corp

BIOE · Pharmaceutical Preparations

CERO THERAPEUTICS HOLDINGS, INC.

CERO · Biological Products, (No Diagnostic Substances)

CV Sciences, Inc.

CVSI · Pharmaceutical Preparations

Cannabis Bioscience International Holdings, Inc.

CBIH · Services-Commercial Physical & Biological Research

PINEAPPLE EXPRESS CANNABIS Co

PNXP · Services-Prepackaged Software

: 11/08/2026